[Federal Register Volume 63, Number 77 (Wednesday, April 22, 1998)]
[Notices]
[Pages 19924-19925]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-10789]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Vaccine Advisory Committee, Subcommittee on Future 
Vaccines, Subcommittee on Immunization Coverage, and Subcommittee on 
Vaccine Safety: Meetings

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following Federal advisory committee 
meetings.

    Name: National Vaccine Advisory Committee (NVAC).
    Times and Dates: 9 a.m.-2 p.m., May 7, 1998. 8:30 a.m.-1:30 
p.m., May 8, 1998.
    Place: Hubert H. Humphrey Building, Room 800, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Notice: In the interest of security, the Department has 
instituted stringent procedures for entrance to the Hubert H. 
Humphrey Building by non-government employees. Thus, persons without 
a government identification card should plan to arrive at the 
building each day either between 8 and 8:30 a.m. or 12:30 and 1 p.m. 
so they can be escorted to the meeting. Entrance to the meeting at 
other times during the day cannot be assured.
    Purpose: This committee advises and makes recommendations to the 
Director of the National Vaccine Program on matters related to the 
Program responsibilities.
    Matters To Be Discussed: Agenda items include updates on the 
National Vaccine Program Office (NVPO) activities and non-
traditional sites for adult immunization: NVAC recommendations and 
guidelines and a presentation on a model system in San Antonio, 
Texas. David Satcher, M.D., Ph.D., the Assistant Secretary for 
Health and Surgeon General, will discuss his new role and 
immunization as a key component in enhancing the health of the 
Nation. Committee discussions on the following: initiatives in 
vaccine communication, strategies for promoting travel vaccines, the 
impact and effects of welfare reform on immunization, vaccines as a 
response to bioterrorism, the status of influenza pandemic 
preparedness, joint vaccine acquisition program--limited use 
vaccines; reports from the Immunization Registries Workgroup, 
Subcommittee on Immunization Coverage, Subcommittee on Future 
Vaccines, and Subcommittee on Vaccine Safety; and a review of fiscal 
year 98 unmet needs.

    Name: Subcommittee on Immunization Coverage.
    Time and Date: 2 p.m.-5 p.m., May 7, 1998.
    Place: Hubert H. Humphrey Building, Room 800, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee identifies and proposes solutions 
that provide a multifaceted and holistic approach to reducing 
barriers that result in low immunization coverage for children.
    Matters To Be Discussed: Agenda items include a review of 
recommendations from the document, ``Strategies to Sustain 
Immunization Coverage,'' and how to sustain immunization coverage 
rates in children.

    Name: Subcommittee on Future Vaccines.
    Time and Date: 2 p.m.-5 p.m., May 7, 1998.

[[Page 19925]]

    Place: Hubert H. Humphrey Building, Room 317B, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee develops policy options and guides 
national activities that lead to accelerated development, licensure, 
and the best use of new vaccines in the simplest possible 
immunization schedules.
    Matters To Be Discussed: Agenda items include discussions on the 
continued evaluation of methods to remove barriers to development, 
licensure, and use of safe and effective new vaccines; combination 
vaccines, strategic options; and defining future vaccines policy 
issues for travelers' vaccines.

    Name: Subcommittee on Vaccine Safety.
    Time and Date: 2 p.m.-5 p.m., May 7, 1998.
    Place: Hubert H. Humphrey Building, Room 800, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee reviews issues relevant to vaccine 
safety and adverse reactions to vaccines.
    Matters To Be Discussed: Agenda items include discussion on 
various vaccine causation hypotheses.
    All agenda items are subject to change as priorities dictate. 
Due to programmatic issues that had to be resolved, this Federal 
Register notice is being published less than 15 days before the date 
of the meeting.

    CONTACT PERSON FOR MORE INFORMATION: Felecia D. Pearson, 
Committee Management Specialist, NVPO, CDC, 1600 Clifton Road, NE, 
M/S A11, Atlanta, Georgia 30333, telephone 404/639-4450.

    Dated: April 17, 1998.
Nancy C. Hirsch,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 98-10789 Filed 4-21-98; 8:45 am]
BILLING CODE 4163-18-P